Meet Dhruv Malhotra, the man who bought Mankind Pharma’s Poonam Juneja’s Delhi property: Know about his journey & net worth Poonam Juneja is the wife of Ramesh Juneja, the founder of Mankind Pharma. 2 years agoMay 31, 2023
Mankind Pharma posts Q4FY23 profit at Rs 285.44 crore, revenue up 18.9% Mankind Pharma posted revenue from operations at Rs 2052.67 crore, up 18.9 per cent as against Rs 1725.76 crore in… 2 years ago
Mankind Pharma says no impact of I-T raids on operational performance Mankind Pharma stated that the Company and its subsidiaries are cooperating with the officials of the Income Tax Department and… 2 years ago
Mankind Pharma share falls 6% today after gaining 32% over IPO price; should you buy, sell or hold? As Mankind Pharma shares fell 6% in trade today following its bumper listing on the bourses yesterday, analysts are mixed… 2 years ago
Mankind Pharma IPO’s success raises revival hopes for moribund public issue market Mankind Pharma IPO was massively oversubscribed, at 15.3 times, at close yesterday. 2 years agoApril 28, 2023
Mankind Pharma IPO Day 3: Issue oversubscribed 15.32 times, QIBs subscribed 4916% for their portion; GMP falls The portion for retail investors remains undersubscribed as investors bid only 0.92 times of the shares reserved for RIIs. The… 2 years ago
Mankind Pharma IPO Day 2: Issue subscribed 87%; QIBs, NIIs overbid for their portion Mankind Pharma shares’ GMP fell to Rs 30 on Wednesday, compared to Rs 92 per equity share on Monday. The… 2 years ago
Meet Ramesh Juneja, chairman of Mankind Pharma; Know about his Rs 34,500 crore net worth, career & more Ramesh Juneja is the chairman of Mankind Pharma which he started with his brother Rajeev Juneja. 2 years agoApril 26, 2023
Mankind Pharma IPO Day 1: Issue subscribed 14%, HNIs subscribed one-third of quota Qualified institutional buyers (QIBs) subscribed for 8% of their reserved portion. Retail investors bid 14,39,737 times of the shares reserved… 2 years ago
Mankind Pharma’s IPO opens tomorrow — Here’s all you need to know Mankind Pharma IPO: During the press conference today, Rajeev Juneja, Managing Director of Mankind Pharma, informed that in the past… 2 years ago
Mankind Pharma eyes $5.26-bn valuation in IPO Sets Rs 1,026-1,080 price band to raise Rs 4,326 crore via OFS route 2 years agoApril 19, 2023
Mankind Pharma IPO to open on April 25; all OFS, no fresh issue, 4 crore shares on sale Mankind Pharma IPO is entirely an offer for sale (OFS) of 40,058,844 equity shares by promoters and other existing shareholders. 2 years agoApril 18, 2023
Mankind Pharma eyes Rs 4,700 crore through IPO “The company is looking to launch the IPO by the end of this month, depending on regulatory approvals. This would… 2 years agoApril 5, 2023
Mankind Pharma reduces price of its heart failure drug by 70 percent in India Studies show that heart failure claims more than 17.9 million lives every year globally whilst, medicines for critically ill heart… 3 years ago
Mankind Pharma invests in Actimed Therapeutics for clinical developments in cancer Following the investment, Atish Majumdar, President (Sales & Marketing) of Mankind Pharma joins Actimed Therapeutics as a member of its… 3 years ago
Mankind Pharma’s HealthOK revamps its multivitamin tablet According to the company, the new consumer-engaging and attractive packaging is intended to symbolise invigorated capacity and to reinforce the… 3 years ago
Mankind Pharma forays into pet-care segment; Launches dog food According to the company, India has seen growth in pet ownership in the last decade which increased during the pandemic. 3 years ago
Mankind Pharma acquires majority stake in Upakarma Ayurveda According to a press statement, Mankind Pharma’s decision to invest in Upakarma Ayurveda will empower the latter to strive to… 3 years ago
Q2FY25: Mankind Pharma’s profit jumps 29 percent to Rs 658.88 crore; Revenue up 13.6% to Rs 3,076.51 crore
Meet Juneja Brothers: How they built Rs 95,876 crore Mankind Pharma, India’s fourth largest pharma company
